U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906769) titled 'Automated Language Analysis in Neurodegenerative Diseases: Application of Artificial Intelligence Models' on Oct. 26.

Brief Summary: This multicenter study aims to characterize the language profiles of patients with various neurodegenerative diseases, including Alzheimer's disease (AD), Primary Progressive Aphasia (PPA), behavioral variant Frontotemporal Dementia (bvFTD), Dementia with Lewy Bodies (DLB), and Parkinson's disease (PD), using artificial intelligence (AI) models. By analyzing speech and language data collected during remote neuropsychological assessments, the researchers intend to identify objective linguistic biomarker...